Follow the event on twitter #IGBAMedicinesforEU

For further information and to register on-line, please visit www.medicinesforeurope.com/events

Lucia Romagnoli - T: +44-7562-876873 - E: events@medicinesforeurope.com

Registrations close officially on 5 June 2017 and are subject to availability.

PROGRAMME

Patients

increasing patient

access

Quality

quality, safety and

efficacy

Value

investors in

innovation

Sustainability

160.000 jobs across

Europe

Partnership

key partners for

public health

Wednesday 14 June

16:30

-

18:30

--PRICING & REIMBURSEMENT--

Pre-Conference Workshop 1: Pricing and Reimbursement Policies around Generic and Biosimilar Medicines

Chair | Michele Uda, Director General – Assogenerici and Chair EMAC – Medicines for Europe

Panel

Hélder Mota-Filipe, Member of the Executive Board – Infarmed

Mario Melazzini, President – AIFA (tbc)

Stanislav Primozic, Head of Sector for Pharmacoeconomics, Pharmacovigilance and HTA – JAZMP

Jaime Espin, Professor – Andalusian School of Public Health

Maria Conceição Portela, Researcher – Universidade Católica Portuguesa (tbc)

Victor Lino Mendonça, Head of Policy and Market Access Europe – Mylan (tbc)

16:30

-

18:30

--ETHICS--

Pre-Conference Workshop 2: International Consensus Framework on Ethics in the Healthcare Sector

Chair | Sophie Peresson, Director, Pharmaceuticals and Healthcare – Transparency International (tbc)

Panel

Ema Paulino, Professional Secretary FIP Executive Committee and President Lisbon and South

Branch of the Portuguese Pharmaceutical Society

Kawaldip Sehmi, Chief Executive Officer – IAPO (tbc)

Sara Perazzi, Membership and Project Manager – International Hospital Federation (tbc)

Edward Kelley, Coordinator and Head of Strategic Programmes, Patient Safety – WHO (tbc)

Heikki Pälve, CEO – Finnish Medical Association

Michael Fadus, Vice President of Compliance – Teva (tbc)

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

16:30

-

18:30

--COMMUNICATIONS--

Pre-Conference Workshop 3: #AccessHealth, what’s behind a hashtag?

Chair | Brett Kobie, Digital, Social and Creative Lead – Fleishman Hillard

Panel

Aidan Fry, Editor – Generics Bulletin

Paul Tunnah, CEO and Founder – Pharmaphorum

Laetitia Tonel, Head of Communications – Mylan Europe

Chris Lewis, Senior Manager External Communications – Sandoz Europe

Doris Casares, Communications Director – Medicines for Europe

James Duggan, Principal Medical Writer – 90TEN/IGBA Communications Project

16:30

-

18:30

--TRADE--

Pre-Conference Workshop 4: Business Opportunities in External Markets and Access to Medicines –

An Assessment of the Global Policy and Markets Committee

Chair | Sergio Napolitano, Legal Affairs and Trade Director – Medicines for Europe

Panel

Alan Sheppard, Principal Thought Leadership Global Generics and Biosimilars – QuintilesIMS

Sérgio Paulo Simões, Vice-President/Head Business and Product Development – Bluepharma

David Jauch, Manager Global Regulatory Affairs, Governmental Relations – Fresenius Kabi

20:00

Welcome Cocktail and Conference Registrations

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

Thursday 15 June

08:00

Welcome Coffee and Registration

09:00

--OPENING ADDRESS--

Jacek Glinka, President – Medicines for Europe

--OPENING KEYNOTE SPEECH--

Adalberto Campos Fernandes, Minister of Health – Portugal (tbc)

09:30

--SUSTAINABILITY--

Better Access, Better Health: our Industry’s Vision on Sustainability of Healthcare

Chair | Adrian van den Hoven, Director General – Medicines for Europe

Panel

Mark Pearson, Deputy Director of Employment, Labour and Social Affairs – OECD (tbc)

Els Torreele, Executive Director Global Access Campaign – MSF

Alex Harris, CEO – International Health Partners

Trevor Mundel, President Global Health Division – Bill & Melinda Gates Foundation (tbc)

Kawaldip Sehmi, CEO – IAPO (tbc)

Pierluigi Antonelli, Head of Western Europe – Sandoz

Jacek Glinka, President – Medicines for Europe

11:00

Networking Coffee break

11:40

--DEVELOPED MARKETS--

Global Update of Generic Medicines in Developed Markets

Chair | Jim Keon, President – Canadian Generic Pharmaceutical Association

Panel

Alan Sheppard, Principal Thought Leadership Global Generics and Biosimilars – QuintilesIMS

Rabia Khan, Health Division – OECD

Jeff Watson, President – Global Generics Apotex

Dipankar Bhattacharjee, President and CEO, Global Generic Medicines Group – Teva (tbc)

Itsuro Yoshida, President – Towa Pharmaceutical and President – JGA (tbc)

13:00

Networking Buffet Lunch

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

14:00 --GLOBAL MANUFACTURING--

Making Generic and Biosimilar Manufacturing

Thrive: A Global Policy

Chair | Maher Kurdi, Managing Director –

Hayat Pharmaceutical Industries (tbc)

Panel

Gianmario Baccalini, President –

Aschinfarma and Chair – European Fine

Chemicals Group

Dinesh Dua, Vice Chairman –

Pharmaceuticals Export Promotion

Council of India

--PROCUREMENT--

A Concerted Approach to Tackle Economic and

Regulatory Aspects of Shortages

Chair | Marc-Alexander Mahl, Executive Vice President,

Business Unit Generic Drugs – Fresenius Kabi

Panel

Annie Pannelay, Principal – Economist

Intelligence Unit

Aida Batista, Director of Professional

Development – EAHP

Marcel van Raay, Director Ministry of Health –

The Netherlands

Dominik Tomek, Board Member – EPF

Henrique Manuel Gil Martins, President - SPMS,

EPE (tbc)

April Wang, Legal Manager - Yung Shin Pharm.

Ind. Co., Ltd. and Chair, International Affairs

Committee – TGPA (tbc)

15:20

Networking Coffee Break

16:00

--INTERNATIONAL CONVERGENCE--

International Regulatory and Supply Chain

Cooperation

Chair | David Gaugh, Senior Vice President,

Sciences and Regulatory Affairs – aam

Panel

Sabine Kopp, Group Lead, Medicines

Quality Assurance – WHO

Hideyuki Kondo, MHLW/PMDA Liaison

Official – EMA (tbc)

Charles (Chuck) Koon, Head of Global

Operations Auditing and Training –

Mylan (tbc)

Mechthild Sander, AET

Sudhansh Pant, Joint Secretary,

Department of Pharmaceuticals – India

(tbc)

--VALUE ADDED MEDICINES--

A New Value Proposition for Patients, Healthcare

Practitioners and Systems

Chair | Christoph Stoller, Senior Vice-President

Generics and Commercial Operations Europe – Teva

and Vice-President – Medicines for Europe

Panel

Mondher Toumi, Professor – University of Aix-

Marseille (tbc)

Robert Johnstone, Board member – EPF

Sampreet Ramachandra, Director Global Portfolio

and Strategic Marketing – Fresenius Kabi

17:20

Closure of the day

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

17:30

--WOMEN & PHARMA--

Post-conference cocktail event: Q&A with influential women in healthcare

Chair | Hanan Sboul, Secretary General – Jordanian Association of Pharmaceutical Manufacturers (tbc)

Panel

Sarah-Jane King, Deputy Head of Unit, Equal Treatment Legislation – DG Justice, European

Commission (tbc)

Carol Lynch, Head Global Biosimilars – Sandoz

Catarina Nobre, President – EPSA

Eleni Antoniadou, President – European Health Parliament (tbc)

Elisabeth Stampa, CEO – Medichem

Heather Bresch, CEO – Mylan (tbc)

20:00

Conference Dinner

Friday 16 June

08:00

Networking Coffee

09:00

--OPENING ADDRESS—

Adrian van den Hoven, Chairman – IGBA

--OPENING SPEECH—

Martin Seychell, Deputy Director General for Health – European Commission DG SANTE (tbc)

José Inácio Faria, MEP – EPP Portugal

09:20

--LEADERSHIP PANEL--

A Discussion with the Global Leaders

Chair | John Hodgson, Executive Editor – In Vivo, Informa Pharma Intelligence Group (tbc)

Panel

Elisabeth Stampa, CEO – Medichem

Heather Bresch, CEO – Mylan (tbc)

Adalberto Campos Fernandes, Minister of Health – Portugal (tbc)

Dipankar Bhattacharjee, President and CEO, Global Generic Medicines Group – Teva (tbc)

Enrique Ordieres, CEO – Cinfa

Jean-Marie Arnaud, CEO – Sanofi Generics

Jeremy Desai, CEO – Apotex Inc.

Umang Vohra, CEO – CIPLA (tbc)

10:40

Networking Coffee Break

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

11:30 --INVESTORS--

Meet the Investors

Chair | tbc

Introduction:

Greg Reh, Vice Chairman, US & Global Life Sciences Leader – Deloitte (tbc)

Panel

Tim Jaksland, Innovation Analyst – Carmignac Risk Managers (tbc)

Randall Stanicky, Analyst – RBC Wealth Management

Carl Icahn, Founder – Icahn Capital Management (tbc)

Craig Frances, President – the Healthcare Private Equity Association (tbc)

Edward Lopez, Marketing Director – Van Eck (tbc)

Dominic Valder, Analyst – FIL (tbc)

Axel Malkomes, Vice Chairman Healthcare Banking – Barclays plc (tbc)

Zoltan Toth, Private Equity Professional (tbc)

Frances Cloud, Managing Director – Pharmacloud

Ulli Jendrik Koop, Managing Partner – Digital Health Ventures (DHV) (tbc)

12:50 Networking Buffet Lunch

14:00

--BIOSIMILAR MEDICINES--

Global Policies of Biosimilar Medicines

Chair | Duncan Emerton, Senior Director,

Syndicated Insights and Analysis – FirstWord

Panel

Brian Lehman, Manager of pharmacy

benefits and policy – Ohio Public Employees

Retirement System (OPERS)

Suzanne McGurn, Assistant Deputy

Minister and Executive Officer – Ontario

Public Drug Programs (tbc)

Hiroyuki Sakamaki, Professor – Tokyo

University of Science

Carol Lynch, Head Global Biosimilars –

Sandoz

--EMERGING MARKETS--

Unlocking Pharma Growth – Emerging Markets

Chair | Rafael Enrique Maciel Martínez, President –

AMEGI

Panel

Jean Mina, Associate Partner – McKinsey &

Company

Maher Kurdi, Managing Director – Hayat

Pharmaceutical Industries (tbc)

Vivian Frittelli, CEO – NAPM

Oleg Syarkevych, Business Development

Director – Farmak

Dilip G Shah, Secretary General – IPA

Hugo Carradinha, Head of Brazil – Mylan (tbc)

Keh Song Hock, Executive Director – Malaysian

Organisation of Pharmaceutical Industries

15:20

--CLOSING REMARKS--

Adrian van den Hoven, Chairman – IGBA

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

SPONSORS

MEDIA PARTNERS